Banque Pictet & Cie’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4,194
Closed -$941K 382
2026
Q1
$941K Sell
4,194
-5,635
-57% -$1.4M 0.01% 276
2025
Q4
$2.37M Sell
9,829
-4,207
-30% -$1.08M 0.01% 199
2025
Q3
$3.84M Sell
14,036
-1,651
-11% -$451K 0.02% 169
2025
Q2
$4.05M Sell
15,687
-1,900
-11% -$453K 0.03% 163
2025
Q1
$3.94M Sell
17,587
-863
-5% -$201K 0.03% 166
2024
Q4
$4.22M Buy
+18,450
New +$4.44M 0.03% 173
2023
Q4
Sell
-7,606
Closed -$1.12M 453
2023
Q3
$1.12M Buy
7,606
+2,478
+48% +$448K 0.01% 257
2023
Q2
$1.12M Buy
+5,128
New +$1.14M 0.01% 319

Other funds holding RMD

Banque Pictet & Cie's RMD Position: Q2 2026 in Review

Banque Pictet & Cie sold out of ResMed (RMD) in Q2 2026, closing a stake of 4,194 shares — an estimated $941K sold.

Banque Pictet & Cie first reported a position in RMD in Q2 2023 and held it in 8 quarters. The position peaked at $4.22M in Q4 2024. 196 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Banque Pictet & Cie reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
  • Banque Pictet & Cie sold 4,194 ResMed shares in Q2 2026, an estimated $941K.
  • Banque Pictet & Cie first reported a position in ResMed in Q2 2023 and held it in 8 quarters.
  • Banque Pictet & Cie's ResMed position peaked at $4.22M in Q4 2024.
  • 196 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Banque Pictet & Cie's 13F filing for Q2 2026, filed 24 Jul 2026.